AAPS PharmSciTech 2007-01-01

Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.

Tatiane Pereira de Souza, Ramón Martínez-Pacheco, José Luiz Gómez-Amoza, Pedro Ros Petrovick

Index: AAPS PharmSciTech 8(2) , Article 34, (2007)

Full Text: HTML

Abstract

The aim of this study was to investigate the feasibility of using Eudragit E as a granulating agent for a spray-dried extract from Phyllanthus niruri to obtain tablets containing a high dose of this product. The granules were developed by wet granulation and contained 2.5%, 5.0%, and 10.0% Eudragit E in the final product concentration. The tablets were produced on a single-punch tablet press by direct compression of granules using 0.5% magnesium stearate as a lubricant. The tablets were elaborated following a 2 x 3 factorial design, where Eudragit E concentration and compression force were the independent variables, and tensile strength and the extract release of the tablets were the dependent variables. All granules showed better technological properties than the spray-dried extract, including less moisture sorption. The characteristics of the granules were directly dependent on the proportion of Eudragit E in the formulation. In general, all tablets showed high mechanical resistance with less than 1% friability, less moisture sorption, and a slower extract release profile. The Eudragit E concentration and compression force of the tablets significantly influenced both dependent variables studied. In conclusion, Eudragit E was efficient as a granulating agent for the spray-dried extract, but additional studies are needed to further optimize the formulations in order to achieve less water sorption and improve the release of the extract from the tablets.


Related Compounds

  • Amino methacrylate...

Related Articles:

Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions.

2012-01-01

[Chem. Pharm. Bull. 60(11) , 1468-73, (2012)]

Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.

2013-11-01

[Drug Dev. Ind. Pharm. 39(11) , 1698-705, (2013)]

Studies on gynaecological hydrophilic lactic acid preparations. Part 5: The use of Eudragit E-100 as lactic acid carrier in intravaginal tablets.

2003-04-01

[Pharmazie 58(4) , 260-2, (2003)]

Evaluation of in vitro dissolution and in vivo oral absorption of dutasteride-loaded eudragit E nanoparticles.

2013-06-01

[Drug Res. (Stuttg.) 63(6) , 326-30, (2013)]

In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.

2002-01-01

[AAPS PharmSciTech 3(4) , E33, (2002)]

More Articles...